{"id":"W3179565049","doi":"10.2147/dddt.s281602","title":"Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date","year":2021,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Type 2 diabetes; Adverse effect; Hypoglycemia; Renal glucose reabsorption; Intensive care medicine; Diabetes mellitus; Diabetes management; Pharmacology; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007139105,0.0004369833,0.0013788,0.0001262369,0.0001270506,0.00004124164,0.0002363638,0.00008273328,0.00005453917],"category_scores_gemma":[0.00003751958,0.0001988283,0.0002289347,0.000381624,0.00007691181,0.00006604823,0.00004733361,0.00006256466,0.000007884826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000730777,"about_ca_system_score_gemma":0.0004914975,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005229791,"about_ca_topic_score_gemma":0.000003048678,"domain_scores_codex":[0.9982007,0.000190623,0.000609603,0.0004192882,0.0002792855,0.0003005135],"domain_scores_gemma":[0.9981298,0.0007309617,0.0002783441,0.0005770421,0.0001869277,0.00009691941],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001216607,0.0004581822,0.00004871331,0.00148384,0.001817353,0.000002801614,0.001547761,5.718617e-7,0.00001487888,0.0000451844,0.002052552,0.9924065],"study_design_scores_gemma":[0.0008485679,0.001593379,0.00003370695,0.005050299,0.001183195,7.615017e-7,0.0001343972,0.00001186269,0.003037708,0.000007149108,0.9878869,0.0002120715],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001901297,0.9908744,0.0001468014,0.0002093462,0.0002414029,0.006560372,0.00001302444,0.00002122692,0.00003211726],"genre_scores_gemma":[0.0001424979,0.9882681,0.007275004,0.0001387681,0.0001081085,0.001789439,0.0001734021,0.00005279938,0.002051838],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9921944,"threshold_uncertainty_score":0.8107982,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1537171038298372,"score_gpt":0.3626358042111746,"score_spread":0.2089187003813374,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}